Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11939346-B2 United States of America 26 Mar 2024
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11851451-B2 United States of America 26 Dec 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11738035-B2 United States of America 29 Aug 2023
COMPOSITIONS AND METHODS OF USE COMPRISING SUBSTANCES WITH NEURAL PLASTICITY ACTIONS… Application EP-4230195-A1 European Patent Office 23 Aug 2023
COMPOSITIONS AND METHODS OF USE COMPRISING SUBSTANCES WITH NEURAL PLASTICITY ACTIONS… Application EP-4219445-A1 European Patent Office 02 Aug 2023
COMPOSITIONS AND METHODS OF USE COMPRISING SUBSTANCES WITH NEURAL PLASTICITY ACTIONS… Application EP-4219490-A1 European Patent Office 02 Aug 2023
COMPOSITIONS AND METHODS OF USE COMPRISING SUBSTANCES WITH NEURAL PLASTICITY ACTIONS… Application EP-4219498-A1 European Patent Office 02 Aug 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11629159-B2 United States of America 18 Apr 2023
COMPOSITIONS AND METHODS OF USE COMPRISING SUBSTANCES WITH NEURAL PLASTICITY ACTIONS… Application EP-3934633-A4 European Patent Office 29 Mar 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11564935-B2 United States of America 31 Jan 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11505564-B2 United States of America 22 Nov 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11447510-B2 United States of America 20 Sep 2022
EFFECTS OF MESCALINE AND OF MESCALINE ANALOGS (SCALINES) TO ASSIST PSYCHOTHERAPY Application WO-2022180497-A1 World Intellectual Property Organisation (WIPO) 01 Sep 2022
Method of treatment based on reduced monoamine oxidase a activity Grant US-11344564-B1 United States of America 31 May 2022
Deuterated derivatives of psilocybin and uses thereof Grant US-11324762-B2 United States of America 10 May 2022
METHOD OF QUANTIFYING PSILOCYBIN'S MAIN METABOLITES, PSILOCIN AND 4-HYDROXYINDOLE-3-ACETIC… Application WO-2022053892-A3 World Intellectual Property Organisation (WIPO) 21 Apr 2022
NOVEL FORMULATIONS OF PSILOCYBIN AND PSILOCIN COMPOUNDS AS SEROTONIN AGONISTS IN… Application WO-2022061196-A1 World Intellectual Property Organisation (WIPO) 24 Mar 2022
METHOD OF QUANTIFYING PSILOCYBIN'S MAIN METABOLITES, PSILOCIN AND 4-HYDROXYINDOLE-3-ACETIC… Application WO-2022053892-A2 World Intellectual Property Organisation (WIPO) 17 Mar 2022
NOVEL PSILOCIN DERIVATIVES HAVING PRODRUG PROPERTIES Application WO-2022038299-A1 World Intellectual Property Organisation (WIPO) 24 Feb 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11180517-B2 United States of America 23 Nov 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11149044-B2 United States of America 19 Oct 2021
Deuterated derivatives of psilocybin and uses thereof Grant US-11000534-B1 United States of America 11 May 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10954259-B1 United States of America 23 Mar 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10947257-B2 United States of America 16 Mar 2021
COMPOSITIONS AND METHODS OF USE COMPRISING SUBSTANCES WITH NEURAL PLASTICITY ACTIONS… Application WO-2020181194-A1 World Intellectual Property Organisation (WIPO) 10 Sep 2020